Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis

Trenova, A., Slavov, G., Manova, M., Draganaova-Filipova, M., Mateva, N., Miteva, L., & Stanilova, S. (). Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis. Scandinavian Journal of Clinical and Laboratory Investigation; Scandinavian Journal of Clinical and Laboratory Investigation.